Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine： a Single-arm, Self-control, Open-label, Single-center Trial

NCT06029153 is registered in ClinicalTrials.gov with The Affiliated Hospital Of Guizhou Medical University as lead sponsor.

NCT NCT06029153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06029153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine： a Single-arm, Self-control, Open-label, Single-center Trial
Lead sponsor
The Affiliated Hospital Of Guizhou Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2023
Completion date
November 30, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine